Lupin Q1 net dips by 16% at Rs 525.02 cr
The company had posted a net profit after taxes and minority interest of Rs 624.74 crore for the corresponding period of the previous fiscal, Lupin said in a filing to BSE.
Jul 23, 2015, 16:08 PM IST
Lupin up 2.5% on Russia's Biocom acquisition
Shares of drug major Lupin on Friday gained 2.5 percent after the company announced acquisition of Russia's Biocom, marking its foray into the Russian pharma market, which is expected to be one of the top eight in the world by 2018.
Jul 03, 2015, 13:43 PM IST
Lupin shares gain on inclusion in Sensex
Shares of drugmaker Lupin rose by almost 2 percent after the stock became part of the BSE benchmark Sensex from on Monday.
Jun 22, 2015, 13:16 PM IST
Lupin submits fresh studies for two products suspended by EMA
The Mumbai-based firm along with many other companies had received communication from EMA for suspension of Trimetazidine MR 35 mg and Cefpodoxime 200 mg tablets in January 2015.
May 26, 2015, 14:10 PM IST
Lupin shares down over 3% on weak earnings
On the NSE, it fell by 3.4 percent to settle at Rs 1,631.95.
May 14, 2015, 18:52 PM IST
